More specifically, reducing ID1 lowered cancer cell expression of endothelial cell genes (e.g. CDH5, TIE2) and production of pro‐angiogenic proteins (e.g. VEGF, CD31, MMP9 and IL‐8). The gene discussed is TEK; the disease is cancer.